Junshi Joins China mRNA Mania Through Immorna JV

Latest Partner For In-Demand Venture

Junshi forms JV with Immorna
Junshi becomes fourth Chinese biopharma firm to collaborate with domestic mRNA specialist Immorna. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Deals

More from Business